Concepedia

Weifeng Song

WS

18

Publications

816

Citations

15

H-Index

2010

Active since

Affiliations

Shanghai First People's Hospital(Current)

Shanghai Jiao Tong University

Hunan Cancer Hospital

Sun Yat-sen University

Fujian Provincial Cancer Hospital

Weifeng Song is an author at Shanghai First People's Hospital specializing in medicine, radiation oncology, and molecular oncology.

Top concepts

Publications per year

2010–2023

18

Publications

18

Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial

Xiangyu Gao, Nong Xu, Ziyu Li et al. · The Lancet Oncology · 2023 · 171 citations

, , +8

EZH2 promotes cell migration and invasion but not alters cell proliferation by suppressing E-cadherin, partly through association with MALAT-1 in pancreatic cancer

Ting Han, Jiao Feng, Hai Hu et al. · Oncotarget · 2016 · 88 citations · Full text

, , +13

AK112, a novel PD-1/VEGF bispecific antibody, in combination with chemotherapy in patients with advanced non-small cell lung cancer (NSCLC): an open-label, multicenter, phase II trial

Yuanyuan Zhao, Gang Chen, Jianhua Chen et al. · EClinicalMedicine · 2023 · 75 citations · Full text

FOXO1-regulated lncRNA LINC01197 inhibits pancreatic adenocarcinoma cell proliferation by restraining Wnt/β-catenin signaling

Ling Jing, Fan Wang, Chuan Liu et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 74 citations · Full text

A multicenter, open-label phase Ib/II study of cadonilimab (anti PD-1 and CTLA-4 bispecific antibody) monotherapy in previously treated advanced non–small-cell lung cancer (AK104-202 study)

Yuanyuan Zhao, Yuxiang Ma, Yun Fan et al. · Lung Cancer · 2023 · 67 citations · Full text

Rows per page

1–5 of 18